Rocket Pharmaceuticals' Series B Round

Rocket Pharmaceuticals raised a round of funding on March 02, 2017. Investors include RTW Investments.

Rocket Pharmaceuticals is focused on emerging gene-modified cell therapies. The company aims to bring hope and relief to patients with under treated rare diseases through the development and commercia…

Articles about Rocket Pharmaceuticals' Series B Round: